Sorrento Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in research, development and manufacturing of some of their biopharmaceutical products.
“We have published that antibodies targeting the ghrelin-mediated appetite process are effective in reducing body weight in established animal models”
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. [Source: MarketWatch]
Company Website: http://sorrentotherapeutics.com/